Overview
- 40 inspections across 36 sites are on record.
- 48 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
40
Sites
36
Observations
48
Career since
Sep 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sincerus Florida, LLC dba SKNV | 29 May 2026 | Human Drugs | |
| Bentley Laboratories LLC | 27 Mar 2026 | Human Drugs | On file |
| GlaxoSmithKline LLC | 20 Feb 2026 | Human Drugs | |
| New Life Pharma LLC | 13 Feb 2026 | Human Drugs | On file |
| Petnet Solutions, Inc. | 19 Sep 2025 | Human Drugs | On file |
Sites inspected
Sincerus Florida, LLC dba SKNVPompano Beach, United States1 insp.
Bentley Laboratories LLCEdison, United States1 insp.
GlaxoSmithKline LLCZebulon, United States1 insp.
New Life Pharma LLCNorthvale, United States1 insp.
Petnet Solutions, Inc.Hackensack, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Janet A Rajan7 shared
Stephenie M Ortiz5 shared
Robin P Mathew4 shared
Anthony J Donato4 shared
Helen Verdel4 shared
Suchan Kim3 shared
Guerlain Ulysse3 shared
Andrew O Ejiofor2 shared
Charlotte P Chang2 shared
Saleem A Akhtar2 shared
Full investigator report
Get the verbatim findings behind Annet R Rajan's 48 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site